MagnetisMM-20
Phase 1B Study Evaluating Elranatamab in Combination with Carfilzomib/Dexamethasone or in Combination with PF-07901801 (maplirpacept) in Relapsed/Refractory Multiple Myeloma
Arms / Cohorts
Experimental: Dose Escalation:Part 1: Elranatamab, Carfilzomib and Dexamethasone
Accepting patients
Experimental:Part 2: Elranatamab and PF-07901801 (maplirpacept)
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.